Liren Tang
Amministratore Delegato presso Welichem Biotech, Inc.
Posizioni attive di Liren Tang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Welichem Biotech, Inc.
 Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Amministratore Delegato | 18/11/2009 | - |
| Presidente | 18/11/2009 | - | |
| Direttore Tecnico/Scientifico/R&S | 17/11/2009 | 18/11/2009 |
Storia della carriera di Liren Tang
Precedenti posizioni note di Liren Tang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Vancouver Coastal Health Research Institute
 Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
Formazione di Liren Tang
| University of British Columbia | Doctorate Degree |
Statistiche
Distribuzione geografica
| Canada | 4 |
Posizioni
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| President | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
Vancouver Coastal Health Research Institute
Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Liren Tang
- Esperienza
